04.12.19
Unilever has signed an agreement to acquire the Fluocaril and Parogencyl oral care brands from Procter & Gamble. The deal is expcted to close in Q2. Terms were not disclosed.
Fluocaril and Parogencyl are well-known therapeutics brands sold in the pharmacy channel, primarily in France and Spain. Fluocaril specializes anti-cavities products; Parogencyl tackles gum issues.
The acquisition will give Unilever a leading position in oral care within the French pharmacy channel as well as strong positions in Spain. With its powerful brand heritage, high awareness and sound reputation amongst dentists, these brands are a great complement to Unilever’s existing oral care portfolio.
Fluocaril and Parogencyl are well-known therapeutics brands sold in the pharmacy channel, primarily in France and Spain. Fluocaril specializes anti-cavities products; Parogencyl tackles gum issues.
The acquisition will give Unilever a leading position in oral care within the French pharmacy channel as well as strong positions in Spain. With its powerful brand heritage, high awareness and sound reputation amongst dentists, these brands are a great complement to Unilever’s existing oral care portfolio.
